Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tianxing Hang"'
Autor:
Qianqian Chen, Chunmei Hu, Wei Lu, Tianxing Hang, Yan Shao, Cheng Chen, Yanli Wang, Nan Li, Linling Jin, Wei Wu, Hong Wang, Xiaoning Zeng, Weiping Xie
Publikováno v:
Journal of biomedical research. 36(3)
Tuberculosis (TB), is an infectious disease caused by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d13bb0e42ed7d687698a414de43ead22
https://pubmed.ncbi.nlm.nih.gov/35635159
https://pubmed.ncbi.nlm.nih.gov/35635159
Autor:
Tianxing, Hang, Li, Yang, Xiujuan, Zhang, Jing, Li, Feng, Long, Ning, Zhu, Ying, Li, Jingwen, Xia, Youzhi, Zhang, Peng, Zhang, Yuanyuan, Zhang, Xiaomin, Wei, Shengqing, Li
Publikováno v:
Am J Transl Res
Objective: The folic acid analog pemetrexed (PMX) is recommended for the first-line chemotherapy for advanced non-squamous non-small cell lung cancer (NSCLC). However, the mechanisms underlying PMX cytotoxicity in NSCLC remain to be fully explored. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::188f211a55523bdc87ffdd3c658c8ea7
https://pubmed.ncbi.nlm.nih.gov/34017390
https://pubmed.ncbi.nlm.nih.gov/34017390
Autor:
Jian He, Ying Li, Shengqing Li, Tianxing Hang, Liying Fang, Liang Dong, Xiujuan Zhang, Jingwen Xia, Mengjie Niu, Yaqin Chai
Publikováno v:
Oncology Letters
First-generation epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have markedly improved the treatment of non-small cell lung cancer (non-SCLC) with EGFR-sensitive mutations. However, acquired resistance to these drugs was ine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a518adc0187995c1acbb2f4712f0f709
https://doi.org/10.3892/ol.2017.6229
https://doi.org/10.3892/ol.2017.6229
Autor:
LIYING FANG, JINGWEN XIA, LIANG DONG, XIUJUAN ZHANG, MENGJIE NIU, TIANXING HANG, SHENGQING LI, YAQIN CHAI, YING LI
Publikováno v:
Oncology Letters; Jul2017, Vol. 14 Issue 1, p593-598, 6p, 1 Color Photograph, 1 Chart